India tightens grip on GLP-1 supply chain amid misuse concerns, expands crackdown on unapproved drugs

India's drug regulator is increasing checks on weight loss drug sales. This action follows inspections of pharmacies and clinics nationwide. The goal is to prevent illegal sales of these specialized medicines. Authorities are also cracking down on unapproved drug combinations. Patient safety is the top priority as regulators enforce rules across the pharmaceutical supply chain.